pubmed.ncbi.nlm.nih.gov

Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4 - PubMed

Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4

Amy Chan et al. Neuromolecular Med. 2007.

Erratum in

  • Neuromolecular Med. 2008;10(1):46. Chan, Amy [added]

Abstract

In addition to cognitive impairment, behavioral changes such as aggressive behavior, depression, and psychosis accompany Alzheimer's Disease. Such symptoms may arise due to imbalances in neurotransmitters rather than overt neurodegeneration. Herein, we demonstrate that combined administration of N-acetyl cysteine (an antioxidant and glutathione precursor that protects against A beta neurotoxicity), acetyl-L-carnitine (which raises ATP levels, protects mitochondria, and buffers A beta neurotoxicity), and S-adenosylmethionine (which facilitates glutathione usage and maintains acetylcholine levels) enhanced or maintain cognitive function, and attenuated or prevented aggression, in mouse models of aging and neurodegeneration. Enhancement of cognitive function was rapidly reversed upon withdrawal of the formulation and restored following additional rounds supplementation. Behavioral abnormalities correlated with a decline in acetylcholine, which was also prevented by this nutriceutical combination, suggesting that neurotransmitter imbalance may contribute to their manifestation. Treatment with this nutriceutical combination was able to compensate for lack of dietary folate and vitamin E, coupled with administration of dietary iron as a pro-oxidant (which collectively increase homocysteine and oxidative damage to brain tissue), indicating that it provided antioxidant neuroprotection. Maintenance of neurotransmitter levels and prevention of oxidative damage underscore the efficacy of a therapeutic approach that utilizes a combination of neuroprotective agents.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Res. 2006 Sep 13;1109(1):201-6 - PubMed
    1. Brain Res. 2000 Nov 10;883(1):31-40 - PubMed
    1. Tidsskr Nor Laegeforen. 1998 Feb 10;118(4):560-5 - PubMed
    1. Drugs Exp Clin Res. 1994;20(4):169-76 - PubMed
    1. Neurobiol Aging. 2006 Nov;27(11):1595-603 - PubMed

MeSH terms

Substances

LinkOut - more resources